Argent Biopharma Limited has released a press release.
Pause in trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Share Purchase Plan Closed
- Pre-clinical Trial Results on CimetrA
- MGC Pharma Launches Share Purchase Plan
- MGC receives permission for first import of Psilocybin
- Commitments Received for GBP 0.7m
Later from Argent Biopharma
- Retraction of Statement
- Company Update & Capital Raising
- Placing to Raise US$500,000
- Placing to Raise US$2,000,000
- Voluntary Delisting from ASX
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma